Blog

Elmiron: Long Term Side Effects and Eye Damage

Have you had prolonged exposure to Elmiron? Are you suffering from vision problems or other Elmiron long term side effects? Many individuals that took Elmiron and experienced vision problems have filed lawsuits against the manufacturer, Janssen Pharmaceuticals. These lawsuits allege that Janssen failed to warn doctors and patients about the risks of vision problems associated with the drug.

Our law firm is investigating vision loss claims nationwide due to Elmiron. Learn more about Elmiron long term side effects and how a lawyer can help you seek justice for vision problems related to the drug.

What Is Elmiron?

Elmiron, or pentosan polysulfate sodium (PPS), is an oral medication used to treat bladder pain or discomfort caused by Interstitial Cystitis (IC). Elmiron side effects, according to the Mayo Clinic include:

  • Vision impairment (i.e. blurry or dimmed vision)
  • Unusual bleeding or bruising
  • Difficulty breathing
  • Fever
  • Sore throat
  • Chills
  • Skin hives or rash

Many of the side effects listed above are rare and short term side effects. However, Elmiron long term side effects, such as loss of close vision, night blindness and other serious vision-related injuries, have affected many patients.

Elmiron Long Term Side Effects and Eye Damage

Long term side effects of Elmiron include loss of close vision, night blindness and other vision impairments. While these Elmiron long term side effects may be temporary, vision problems may result in permanent eye damage.

Eye damage and blindness is a serious risk associated with the drug. Elmiron appears to be toxic to the retina and is associated with retinal damage. Retina is the light-sensing tissue that supports the ability to see. According to a recent study by the American Academy of Ophthalmology, nearly 25 percent of patients that participated in the study showed “clear signs of drug toxicity” and the rate of toxicity rose with the amount of medication consumed.

Studies Link Use of Elmiron to Vision Threatening Eye Condition

In 2018, a study by the American Academy of Ophthalmology concluded that chronic exposure to Elmiron was associated with a unique and avoidable maculopathy. Patients in this original study suffered from the following symptoms:

  • Prolonged adaptation to darkness
  • Difficulty reading

What Is Maculopathy?

Maculopathy, or macular degeneration, is a disease that affects the macula, which is the central part of the retina.

Elmiron and Pigmentary Maculopathy

A form of maculopathy associated with chronic use of Elmiron is called pigmentary maculopathy. Pigmentary maculopathy may be misdiagnosed as a similar-appearing condition. For example, conditions such as age-related macular degeneration (AMD) and pattern dystrophy may be mistaken for the unique maculopathy associated with Elmiron.

Similar conditions that may be mistaken for pigmentary maculopathy include:

  • Age-related Macular Degeneration (AMD)
  • Pattern Dystrophy
  • Cellophane Maculopathy
  • Malattia Leventinese

It is critical that patients exposed to Elmiron be screened and examined by a medical professional who is experienced in diagnosing pigmentary maculopathy.

Questions About an Elmiron Lawsuit? Call for a Free Consultation

If you are experiencing vision problems or other Elmiron long term side effects, request a free consultation. Our experienced attorneys are investigating vision loss claims due to Elmiron and taking cases nationwide. Contact us by submitting the form or by calling us at (866) 575-7435 for a confidential evaluation of your potential claim.

Elmiron Manufacturer Updates U.S. Drug Label to Warn of Potential Eye Damage

As litigation against Janssen Pharmaceuticals, manufacturer of bladder pain drug Elmiron, mounts, the FDA has approved a change in the drug’s labeling in the U.S. The label of the drug’s “Warnings” section previously did not list any risks concerning visual impairment; however, labeling must now contain “Retinal Pigmentary Changes.” These changes may manifest as pigmentary maculopathy, a condition affects the central portion of the retina, which senses light. Pigmentary maculopathy, as well as other vision impairment symptoms, have been linked to long-term use of Elmiron. Lawsuits have been filed by Elmiron patients concerning vision damage, and claiming Janssen failed to warn patients of these risks.

You may be legally entitled to compensation if you took Elmiron and were diagnosed with a vision disorder or experienced vision loss symptoms. Contact us by submitting the form or by calling us at (866) 575-7435 for a confidential evaluation of your potential claim.

Lawsuit Alleges Vision Injury, Pigmentary Maculopathy Due to Elmiron Use

In one of the first cases concerning eye damage related to drug Elmiron, the complaint filed in New Jersey Superior Court alleges failure to warn of the drug’s side effects. Elmiron is a prescription drug widely used to treat a bladder pain condition known as interstitial cystitis. Concerns relating to potentially permanent vision loss and other eye damage have recently been raised, in conjunction with long-term use of the drug. These concerns include pigmentary maculopathy, a retinal disease.

The plaintiff in this case was part of a study published in 2018 linking vision damage to long-term Elmiron use. Her lawsuit alleges that Janssen Pharmaceuticals, Elmiron’s manufacturer, knew about the risks for potential eye problems, but failed to provide adequate warnings to patients and doctors.

You may be legally entitled to compensation if you took Elmiron and were diagnosed with a vision disorder or experienced vision loss symptoms. Contact us by submitting the form or by calling us at (866) 575-7435 for a confidential evaluation of your potential claim.

Another Wright Profemur Hip Case Filed as Plaintiffs Push for MDL

A complaint was recently filed against Wright Medical Technology, Inc. and Microport Orthopedics, Inc, manufacturer of the Profemur hip replacement. The June 5, 2020 lawsuit alleges that defendants knew for years—but did not adequately warn—that the Profemur Modular Hip System implant was defectively designed.

Defects include the tendency for the device to corrode, fracture, or fail prematurely. Additional risks of other serious injuries, such as metallosis, tissue damage, pseudotumor, adverse local tissue reaction, and elevated metals released into a patient’s body.

This case joins dozens of others filed across the country alleging similar problems. In May 2020, plaintiffs’ requested that their cases be centralized before one judge in a multi-district litigation to streamline pretrial proceedings.

If you or a loved one suffered complications after receiving a Profemur Modular Hip System implant since August 1, 2009, please contact us by submitting the form or by calling us at 888-894-8946 for a confidential evaluation of your potential claim.

New Jersey Care Facility Faces Class Action Lawsuit Over COVID-19 Deaths

A long-term care facility in New Jersey faces claims that it failed to diagnose residents with COVID-19 in a timely manner, leading to the deaths of nearly 100 patients. The families, some of which were paying nearly $9,000 a month for the facility to care for their loved ones, allege negligence, wrongful death, and medical malpractice in their lawsuit.

The lawsuit claims the facility’s management only provided masks to registered nurses, but not other staff members who interacted with residents such as housekeepers, recreation therapists and nursing assistants. In April 2020, nearly 20 bodies were found piled in the care home’s makeshift morgue.

Like other coronaviruses, COVID-19 affects people of all ages. However, this novel coronavirus can particularly affect vulnerable populations such as the elderly and people with pre-existing medical conditions. Oftentimes, these individuals depend upon in long-term care facilities, such as nursing homes and assisted living communities. Residents of these facilities are particularly susceptible to contracting COVID-19.

Want to Know if You Have a Valid Legal Claim?

If you or a loved one was injured or died due to a long-term care facility failure concerning COVID-19, please contact our law firm. You may be legally entitled to compensation. Schedule a free confidential evaluation of your potential claim by submitting the form below or by calling us at (866) 573-1787

Real Time Analytics